House Dust Mite Allergy Evidence-Based Management-Separating Truth from Fiction Webinar

May 9, 2019

Patients with house dust mite allergy and asthma comprise a major number of patients cared for by the allergist. This activity will review the latest published data on house dust mite management and break many of the myths of “what works best” for our patients. 

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 1 AMA PRA Category I Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgement
This activity was supported by an independent educational grant from ALK-Abelló, Inc.

 

Target Audience

Allergists, allied health and other allergy practitioners.

Learning Objectives

  1. Describe how effective indoor dust mite reduction is in improving allergy and asthma control
  2. Summarize the efficacy and value of pharmacologic agents in decreasing symptoms related to house dust mites
  3. Compare subcutaneous to sublingual tablet immunotherapy in relief of house dust mite allergy and asthma from the latest published data
  4. Be able to employ shared decision making for house dust mite immunotherapy in your practice setting
Additional information
Disclosure: 
Eli Meltzer, MD, FACAAI
ALK Consultant, Speaker Honorarium, Consulting fee
AstraZeneca Consultant Consulting fee
Boehringer-Ingelheim Consultant Consulting fee
GlaxoSmithKline Consultant Consulting fee
Glenmark: Consultant, Speaker; Consulting Fee,
Honorarium. GossamerBio: Consultant; Consulting Fee.
Merck: Consultant; Consulting Fee. Mylan: Consultant;
Consulting Fee. Regeneron/Sanofi: Consultant,
Speaker; Consulting Fee, Honorarium.
John Oppenheimer, MD, FACAAI
Teva Consultant, Consulting fee
DBV Technologies, Consultant, Consulting fee
GlaxoSmithKline, Consultant, Consulting fee
MedImmune Adjudication, Consulting fee
Sanofi Consultant, Consulting fee
Up to Date Reviewer, Honorarium
Medscape Senior Editor, Honorarium
Michael Blaiss, MD, FACAAI
ALK Consultant, Consulting fee
Boston Scientific Consultant, Consulting fee
Pfizer Consultant, Consulting fee
PMD Healthcare Consultant, Consulting fee
RX Bands Consultant, Consulting fee
Stallergenes Consultant, Consulting fee
 
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Course opens: 
05/09/2019
Course expires: 
05/08/2022
Event starts: 
05/09/2019 - 7:00pm
Event ends: 
05/09/2019 - 8:00pm
Rating: 
0

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Accreditation Period

Course opens: 
05/09/2019
Course expires: 
05/08/2022
Please login or create an account to take this course.